Diabetologia

, Volume 27, Issue 1, pp 27–31 | Cite as

Covalently-linked insulin dimers: their metabolism and biological effects in vivo as partial competitive antagonists of insulin clearance

  • M. A. Tatnell
  • R. H. Jones
  • P. H. Sönksen
Originals

Summary

The biological properties of three covalently-linked insulin dimers were studied in greyhounds. Constant infusions showed that the plasma distribution kinetics were slower for the dimers than for insulin. The metabolic clearance rates of the three dimers (10.3±0.4, 8.8±0.5, 8.2±0.5 ml· min-1· kg-1; mean ± SEM) were significantly lower than that of insulin (19±0.8 ml · min-1 · kg-1), and their hypoglycaemic effects (11.2%, 3% and 0.3%) were markedly reduced compared with their lipogenic potencies in vitro (80%, 30% and 13%, respectively). A low dose infusion of insulin or an equipotent dose of one of the dimers significantly prolonged the effects of an insulin bolus on plasma glucose but not on non-esterified fatty acids. The apparent distribution space (106.4±11.9 ml/kg) and clearance rate (14.7±0.5 ml · min-1 · kg-1) of an insulin bolus were significantly reduced by one dimer (44.5±8.4 ml/ kg and 10.7±2.8ml·min-1·kg-1) but not by the equipotent insulin infusion (102.7±8.2ml/kg and 16.4±0.07ml· min-1 · kg-1). The apparent partial competitive antagonism of insulin by the dimers that has been reported in vitro can be observed in vivo, in that antagonism of insulin metabolism was directly demonstrated with one of the dimers.

Key words

Chemically-modified insulins insulin structure-function bioactivity and metabolism in vivo competitive antagonism hypoglycaemia non-esterified fatty acids 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jones RH, Dron DI, Ellis MJ, Sönksen PH, Brandenburg D (1976) Biological properties of chemically modified insulins. I. Biological activity of proinsulin and insulin modified at A1-glycine and B29-lysine. Diabetologia 12: 601–608Google Scholar
  2. 2.
    The Peking Insulin Structure Research Group (1974) Studies on the insulin crystal structure: the molecule at 1.8 A resolution. Sci Sin 17: 752–778Google Scholar
  3. 3.
    Pullen RA, Lindsay DG, Wood SP, Tickle IJ, Blundell TL, Wollmer A, Krail G, Brandenburg D, Zahn H, Gliemann J, Gammeltoft S (1976) Receptor-binding region of insulin. Nature 259: 369–373Google Scholar
  4. 4.
    Jones RH, Quine KH, Tatnell MA, Dron DI, Brandenburg D, Lindsay D (1977) Chemically modified insulins: the relationship between biological activity and metabolism. Diabetologia 13: 405 (Abstract)Google Scholar
  5. 5.
    Willey KP, Tatnell MA, Jones RH, Schüttler A, Brandenburg D (1980) Biological properties of covalent insulin dimers. In: Brandenburg D, Wollmer A (eds) Insulin chemistry, structure, and function of insulin and related hormones. deGruyter, Berlin New York, pp 425–431Google Scholar
  6. 6.
    Thomas SL, Wisher MH, Brandenburg D, Sönksen PH (1979) Insulin action on adipocytes. Biochem J 184: 355–360Google Scholar
  7. 7.
    Schüttler A, Brandenburg D (1982) Preparation and properties of covalently-linked insulin dimers. Hoppe-Seyler's Z Physiol Chem 363: 317–330Google Scholar
  8. 8.
    Dole VP, Meinertz H (1960) Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 235: 2595–2599Google Scholar
  9. 9.
    Sönksen PH, Tompkins CVT, Srivastava MC, Nabarro JDN (1973) A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin Sci Mol Med 45: 633–654Google Scholar
  10. 10.
    Morgan CR, Lazarow A (1963) Immunoassay of insulin. Two antibody system plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12: 115–126Google Scholar
  11. 11.
    Tatnell MA, Jones RH (1981) Effects of pH and NaCl concentrations on binding of covalently-linked insulin dimers to liver plasma membranes. Hoppe-Seyler's Z Physiol Chem 362: 1315–1321Google Scholar
  12. 12.
    Wick AN, Drury DR (1958) Effects of superimposed native insulin on disposal of iodoinsulin in the body. Proc Soc Exp Biol Med 97: 514–416Google Scholar
  13. 13.
    Schade DS, Eaton RP (1977) Dose response to insulin in man: differential effects on glucose and ketone body regulation. J Clin En-docrinol Metab 44: 1038–1053Google Scholar
  14. 14.
    Cheng JS, Kalant K (1970) Effects of insulin and growth hormone on the flux rates of plasma glucose and free fatty acids in man. J Clin Endocrinol 31: 647–653Google Scholar
  15. 15.
    Brown PM, Tompkins CV, Juul S, Sönksen PH (1978) Mechanism of the action insulin in diabetic patients: a dose related effect on glucose production and utilisation. Br Med J 1: 1239–1242Google Scholar
  16. 16.
    Tompkins CV, Brandenburg D, Jones RH, Sönksen PH (1981) Mechanism of action of insulin and insulin analogues. Diabetologia 20: 94–101Google Scholar
  17. 17.
    Cherrington AD, Vranic M (1974) Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatised dogs. Metabolism 23: 729–744Google Scholar
  18. 18.
    Cryer PE (1981) Glucose counterregulation in man. Diabetes 30: 261–266Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • M. A. Tatnell
    • 1
  • R. H. Jones
    • 1
  • P. H. Sönksen
    • 1
  1. 1.Department of MedicineSt. Thomas' Hospital Medical SchoolLondonUK

Personalised recommendations